Compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells

Details for Australian Patent Application No. 2009311748 (hide)

Owner Index Pharmaceuticals AB

Inventors Admyre, Charlotte; Axelsson, LarsGoran; Von Stein, Oliver; Zargari, Arezou

Agent Shelston IP

Pub. Number AU-A-2009311748

PCT Pub. Number WO2010/053430

Priority 61/111,284 04.11.08 US; 0802338-4 04.11.08 SE

Filing date 28 October 2009

Wipo publication date 14 May 2010

International Classifications

C12N 15/117 (2010.01) Mutation or genetic engineering - Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/7125 (2006.01) - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

14 April 2011 PCT application entered the National Phase

  PCT publication WO2010/053430 Priority application(s): WO2010/053430

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009311753-Compounds and methods for the treatment of inflammatory diseases of the CNS

2009311738-Tool for applying torque